Cargando…
Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy
Recent clinical studies suggest that adoptive transfer of donor-derived natural killer (NK) cells may improve clinical outcome in hematological malignancies and some solid tumors by direct anti-tumor effects as well as by reduction of graft versus host disease (GVHD). NK cells have also been shown t...
Autores principales: | Kang, Lin, Voskinarian-Berse, Vanessa, Law, Eric, Reddin, Tiffany, Bhatia, Mohit, Hariri, Alexandra, Ning, Yuhong, Dong, David, Maguire, Timothy, Yarmush, Martin, Hofgartner, Wolfgang, Abbot, Stewart, Zhang, Xiaokui, Hariri, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640206/ https://www.ncbi.nlm.nih.gov/pubmed/23641243 http://dx.doi.org/10.3389/fimmu.2013.00101 |
Ejemplares similares
-
Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy
por: Zhang, Xiaokui, et al.
Publicado: (2015) -
Erythrocyte Enrichment in Hematopoietic Progenitor Cell Cultures Based on Magnetic Susceptibility of the Hemoglobin
por: Jin, Xiaoxia, et al.
Publicado: (2012) -
Human placenta-derived adherent cells induce tolerogenic immune responses
por: Liu, Wei, et al.
Publicado: (2014) -
Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Mediate Protection Against Influenza A Viral Infection
por: He, Shuyang, et al.
Publicado: (2020) -
Selection and expansion of natural killer cells for NK cell-based immunotherapy
por: Becker, Petra S. A., et al.
Publicado: (2016)